Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumors.
Int J Clin Pharmacol Ther
; 47(1): 58-60, 2009 Jan.
Article
in En
| MEDLINE
| ID: mdl-19203540
Search on Google
Database:
MEDLINE
Main subject:
Ruthenium Compounds
/
Indazoles
/
Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Year:
2009
Type:
Article